VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...

AUSTIN, TX / ACCESS Newswire / June 20, 2025 / Action Behavior Centers, a leading provider of compassionate applied behavior analysis (ABA) therapy for children with autism, hosted its inaugural ...

NEW YORK, NY AND RABAT, MOROCCO / ACCESS Newswire / June 20, 2025 / DeepEcho, an AI first healthtech company revolutionizing maternal and fetal health, has received clearance from the U.S. Food and ...

CHICAGO, IL / ACCESS Newswire / June 20, 2025 / Dr. John Peloza, internationally recognized spine surgeon and innovator in spinal motion preservation, will join the keynote panel "Cervical ...

Independent report confirms Ambience Healthcare's AI platform reduces clinician burnout, enhances patient care, and strengthens financial and compliance outcomes SAN FRANCISCO, CA / ACCESS Newswire / ...

SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on ...

In a world increasingly shaped by scientific advancement and evolving societal norms, the realm of human reproduction has ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumorsNew candidate APVO455 targets Nectin-4+ cancers, joins ...

Exhibiting Next Week at HFMA Annual Conference in Denver DENVER, COLORADO / ACCESS Newswire / June 20, 2025 / IKS Health has been named the top-rated provider of outsourced Revenue Cycle Management ...

The global MRI market will rise from USD 6.47 billion in 2025 to USD 9.76 billion by 2035, growing at a CAGR of 4.2%. By product type, closed MRI systems will dominate with a 68.5% share in 2025, ...

The global animal artificial insemination market is valued at USD 2.4 billion in 2025 and is slated to be worth USD 4.2 billion by 2035, expanding at a CAGR of 5.4%. This growth is primarily driven by ...